Belpointe Asset Management LLC Pa Vmed Inc. Transaction History

Belpointe Asset Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.35 - $0.56 $28,055 - $44,888	-80,158 Reduced 84.24%	15,000 $6,000
Q4 2022 Feb 08, 2023	BUY	$0.41 - $18.6 $39,014 - $1.77 Million	95,158 New	95,158 $45,000
Q4 2021 Feb 15, 2022	SELL	$2.46 - $8.74 $86,100 - $305,900	-35,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$5.1 - $9.39 $76,500 - $140,850	-15,000 Reduced 30.0%	35,000 $299,000
Q2 2021 Aug 09, 2021	SELL	$3.95 - $6.88 $59,250 - $103,200	-15,000 Reduced 23.08%	50,000 $320,000
Q1 2021 May 14, 2021	SELL	$2.01 - $5.55 $412,049 - $1.14 Million	-205,000 Reduced 75.93%	65,000 $289,000
Q4 2020 Feb 16, 2021	SELL	$1.73 - $2.13 $51,900 - $63,900	-30,000 Reduced 10.0%	270,000 $572,000
Q3 2020 Nov 13, 2020	BUY	$1.76 - $2.17 $566,720 - $698,740	322,000 Added 97.58%	652,000 $1.29 Million
Q3 2020 Nov 13, 2020	SELL	$1.76 - $2.17 $619,520 - $763,840	-352,000 Reduced 53.99%	300,000 $534,000
Q2 2020 Jul 20, 2020	SELL	$1.75 - $2.65 $563,500 - $853,300	-322,000 Reduced 49.39%	330,000 $696,000
Q2 2019 Nov 22, 2019	BUY	$1.03 - $1.32 $671,560 - $860,640	652,000 New	652,000 $0

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $52.8M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Belpointe Asset Management LLC with notifications on news.